Clin Mol Hepatol.  2012 Sep;18(3):258-267. 10.3350/cmh.2012.18.3.258.

Changes of guidelines diagnosing hepatocellular carcinoma during the last ten-year period

Affiliations
  • 1Department of Internal Medicine, The Catholic University of Korea College of Medicine, Seoul, Korea. baesh@catholic.ac.kr

Abstract

Hepatocellular carcinoma (HCC) is the third most common cause of cancer deaths in the world. There have been many advances in the diagnosis of HCC during the last ten years, especially in the imaging techniques. The Korean Liver cancer study group (KLCSG), European Association for the Study of the Liver (EASL), American Association for the Study of Liver disease (AASLD), and Asian-Pacific Association for the Study of Liver (APASL) have made and changed the HCC guidelines with the advances in the imaging techniques and according to the results of the researches on HCC. We reviewed the changes of the imaging guidelines in HCC diagnosis according to the advances in the imaging techniques. Further studies will be necessary to resolve the controversies in the diagnosis of HCC smaller than 1 cm in size.

Keyword

Hepatocellular carcinoma; Diagnosis; Guideline

MeSH Terms

Carcinoma, Hepatocellular/complications/*diagnosis/pathology
Hepatitis B/complications
Hepatitis C/complications
Humans
Liver Cirrhosis/complications
Liver Neoplasms/complications/*diagnosis/pathology
Magnetic Resonance Imaging
*Practice Guidelines as Topic
Risk Factors
alpha-Fetoproteins/analysis
Full Text Links
  • CMH
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2022 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr